The latest closing stock price for Kymera Therapeutics as of June 05, 2025 is 47.66.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $433 today, roughly 0 times their original investment - a 7.46% compound annual growth rate over 5 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 11.8% above the current share price.
The Kymera Therapeutics 52-week low stock price is 19.45, which is 59.2% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 39.29.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $433 today, roughly 0 times their original investment - a 7.46% compound annual growth rate over 5 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 11.8% above the current share price.
The Kymera Therapeutics 52-week low stock price is 19.45, which is 59.2% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 39.29.